| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/28/2009 | CN101353664A siRNA molecule expression vector for specific inhibition of IL-6 receptor protein expression, and construction method and use thereof |
| 01/28/2009 | CN101353663A Anti-I type diabetes fuse protein and preparation thereof |
| 01/28/2009 | CN101353662A Method of elevating GGT activity of plant, plant with elevated GGT activity and method of constructing the same |
| 01/28/2009 | CN101353661A Genes having delta 6 fatty acid dehydrogenase function and use thereof |
| 01/28/2009 | CN101353660A Improved in vivo production of cephalosporins |
| 01/28/2009 | CN101353659A Method for preparing dissolvable high activity recombinant human epidermal growth factor |
| 01/28/2009 | CN101353658A 新型植物表达构建物 The new plant expression construct |
| 01/28/2009 | CN101353657A Construction method and use of pig Sirtl siRNA expression vector |
| 01/28/2009 | CN101353656A siRNA inhibiting expression of epidermal growth factor receptor genes and use thereof |
| 01/28/2009 | CN101353655A siRNA inhibiting expression of vascular endothelial growth factor receptor genes and use thereof |
| 01/28/2009 | CN101353652A Chaetomium cupreum chitinase ChBD deletion mutant, genes thereof, preparation and used primer |
| 01/28/2009 | CN101353649A Esterase, encoding genes and use thereof |
| 01/28/2009 | CN101353647A Simulating retrovirus of target tumor, and preparation and use thereof |
| 01/28/2009 | CN101353646A Telomerase immortalized human fetal forebrain neural precursor cell line and construction method thereof |
| 01/28/2009 | CN101353645A Granulocyte-macrophage colony stimulating factor gene modified allogene tumour cell vaccine |
| 01/28/2009 | CN101353630A Method for obtaining high yield goosey type antalzyme |
| 01/28/2009 | CN101353381A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 01/28/2009 | CN101353378A Zone 2 protein of programmed cell death protein 2 analogue and uses thereof |
| 01/28/2009 | CN101353377A Zone 1 protein of programmed cell death protein 2 analogue and uses thereof |
| 01/28/2009 | CN101353376A Protein related to rice ear sprouting period and encoding genes and uses thereof |
| 01/28/2009 | CN101353375A Method for producing influenza hemagglutinin multivalent vaccine |
| 01/28/2009 | CN101353374A Pronucleus expressed hepatitis a virus recombinant antigen |
| 01/28/2009 | CN101353372A Novel protein molecular orientation evolvement method |
| 01/28/2009 | CN101353371A H5 subtype avian influenza virus neutralization epitope peptide mimics and uses thereof |
| 01/28/2009 | CN101353364A Method for obtaining small RNA from murine brain |
| 01/28/2009 | CN101352166A Sequences |
| 01/28/2009 | CN101352157A Method for constructing chicken model for transgenosis and production exogenous protein |
| 01/28/2009 | CN100455669C Microorganisms and processes for enhanced production of pantothenate |
| 01/28/2009 | CN100455667C Fusion gene vector construction and expression as well as uses |
| 01/28/2009 | CN100455666C Synergistic control Gene of AtbHLH29 for plant ferro element absorb and its coded protein and uses |
| 01/28/2009 | CN100455665C Upstream transcription control element for human oesophagus cancer cell ezrin gene |
| 01/28/2009 | CN100455600C Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 01/28/2009 | CN100455599C Gene recombinant antibody and its fragment |
| 01/28/2009 | CN100455598C Antibody of anti human CD20 from human resources functionally, and application |
| 01/28/2009 | CN100455597C Process of high purity albumin production |
| 01/28/2009 | CN100455596C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/28/2009 | CN100455595C Protein of interreaction with karyomitosis primary activator protein kinase p38 and its coding gene and application |
| 01/27/2009 | US7483554 Pathological tissue mapping |
| 01/27/2009 | US7482515 Soybean variety XB19Z07 |
| 01/27/2009 | US7482514 Soybean cultivar 1686017 |
| 01/27/2009 | US7482513 Soybean variety XB11L06 |
| 01/27/2009 | US7482512 Lettuce cultivar Del Sol |
| 01/27/2009 | US7482511 Transcription factor stress-related proteins and methods of use in plants |
| 01/27/2009 | US7482510 expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress (drought, cold, oxidation) |
| 01/27/2009 | US7482509 Transgenic plants carrying neoxanthin cleavage enzyme gene |
| 01/27/2009 | US7482508 Providing cells of cotton plants with chimeric gene comprising operably linked DNA fragments (which contain promoter, enzyme, and region involved with transcription termination and polyadenylation); transgenic cells, seeds, plants |
| 01/27/2009 | US7482507 Methods of screening agents for activity using teleosts |
| 01/27/2009 | US7482506 Ras p27 mouse models and uses thereof |
| 01/27/2009 | US7482441 Artificial chromosomes comprising EHV sequences |
| 01/27/2009 | US7482440 Hemopoietin receptor protein, NR10 |
| 01/27/2009 | US7482436 Human antihuman interleukin-6 antibody and fragment of antibody |
| 01/27/2009 | US7482435 Immunoglobulin for use in human therapeutics and diagnostics |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 01/27/2009 | US7482432 Protein for use as tool in controlling plant pest; pesticides; biological pest control; moths and beetles |
| 01/27/2009 | US7482431 KCNQ2 potassium channels |
| 01/27/2009 | US7482428 Optimized expression of HPV 31 L1 in yeast |
| 01/27/2009 | US7482427 Synthetic peptides having a non growth factor heparin binding region, a linker, and sequences; treatment of bone lesions, degenerative joint disease and to enhance bone formation |
| 01/27/2009 | US7482332 For therapy of macular degeneration, the effects of skin aging, liver degeneration, and cancer |
| 01/27/2009 | US7482331 Treating myocardial failure in a human by administering an effective amount of a transgene encoding for alpha-MHC, wherein expression of alpha-MHC provides improvement in left ventricular ejection fraction |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482324 Bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 01/27/2009 | US7482323 Intracellular interleukin-1 receptor antagonist and uses thereof |
| 01/27/2009 | US7482320 Modulation of smooth muscle cell proliferation |
| 01/27/2009 | US7482319 delivery of enzyme, a pharmaceutical agent, a plasmid, a polynucleotide, a polypeptide, a sensor to an organism, tissue or cell by incorporting into a vault like particle such as polypeptide, linked to MVP, VPARP, a portion of VPARP, or a modified MVP, VPARP; adminstering |
| 01/27/2009 | US7482318 Administering polynucleotides, BCL genes or proteins, fusion proteins and/or carrier mixtures, as antiapoptotic agents |
| 01/27/2009 | US7482171 Angiotensin converting enzyme homolog and uses therefor |
| 01/27/2009 | US7482160 Process of making a compound by forming a polymer from a template drug |
| 01/27/2009 | US7482159 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 01/27/2009 | US7482157 Monacolin K biosynthesis genes |
| 01/27/2009 | US7482156 Hepatocellular carcinoma specific promoter and uses thereof |
| 01/27/2009 | US7482155 chimeric construct comprising a smooth muscle cells (SMC)-specific promoter operably linked to a muscle-specific enhancer; expression cassette comprising such a chimeric construct to control expression of a therapeutic gene |
| 01/27/2009 | US7482151 Alleviating or preventing the accumulation of ammonia in a medium via microorganisms that oxidize ammonia to nitrite; bioremediation; biodegradation |
| 01/27/2009 | US7482148 Recombinant calf-chymosin and a process for producing the same |
| 01/27/2009 | US7482147 polypeptides, proteins or fusion proteins having hydrolase enzyme activity, used for medical diagnosis and therapy |
| 01/27/2009 | US7482141 Methods and compositions for vitamin K epoxide reductase |
| 01/27/2009 | US7482138 PAK5-related compositions and methods |
| 01/27/2009 | US7482137 glycosylation endproducts of polyketides, glycoproteins or polyketide-peptide substrates with microbial glycosyltransferases |
| 01/27/2009 | US7482136 Secretase for use in identifying modulator for treatment and prevention of alzheimers disease |
| 01/27/2009 | US7482117 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 01/27/2009 | US7482116 Compositions and methods for obtaining nucleic acids from sputum |
| 01/27/2009 | US7482032 For preventing various kinds of damage resulting from oxidation and exposure to ultraviolet light; for use in food, cosmetics and medicine |
| 01/27/2009 | US7482015 Optimized expression of HPV 45 L1 in yeast |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482012 Streptococcus pyogenes polypeptides and corresponding DNA fragments |
| 01/27/2009 | US7482008 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
| 01/27/2009 | US7482007 Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodies |
| 01/27/2009 | US7482006 Culturing yeasts, host cells; biosynthesis |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | US7482002 Method of administering and using VEGF inhibitors for the treatment of prostate cancer |
| 01/27/2009 | US7482001 Method of administering and using VEGF inhibitors for the treatment of non small cell lung cancer |
| 01/27/2009 | US7481998 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 01/27/2009 | US7481997 Snow mountain virus genome sequence, virus-like particles and methods of use |
| 01/27/2009 | US7481179 In ovo activation of an egg in the shell |
| 01/27/2009 | CA2403973C Heating specimen carriers |
| 01/27/2009 | CA2380783C Human monoclonal antibodies to prostate specific membrane antigen |
| 01/27/2009 | CA2377508C Pcr primer constructs for use in an integrated signalling system |
| 01/27/2009 | CA2360762C Sebocytes, sebocyte cell lines and applications thereof |
| 01/27/2009 | CA2353483C Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides |
| 01/27/2009 | CA2331300C Improvements in or relating to plants and plant products |
| 01/27/2009 | CA2323834C Vectors for gene mutagenesis and gene discovery |